Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATLANTE: ESP Block vs Morphine for Vertebral Fixation Pain
NCT04729049Completed
- Sponsor
- AUSL Romagna
- Start
- Feb 2021
- Primary completion
- Jun 2022
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by AUSL Romagna. Primary endpoint: Postoperative morphine consumption at 48 hours. Started Feb 2021; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04729049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04729049.